Chair Introduction: Practical Considerations for Establishing Flexible, Scalable Manufacturing

Chairperson: Fernanda Masri, Head Of Manufacturing Innovation BD, Cell and Gene Therapy Catapult

Presentation: Balancing Time, Cost and Quality: Considerations when Developing Flexible, Scalable Manufacturing Strategies

• The critical factors – keeping time, quality and cost balanced when establishing ATMP manufacturing capabilities.
• Navigating the evolving landscape – options for flexible and scalable manufacturing strategies

Katey Adcock, Director of Operations, Stevenage Manufacturing Innovation Centre, Cell and Gene Therapy Catapult

Panel: Achieving Seamless Technology Transfer 

Katey Adcock, Director of Operations, Stevenage Manufacturing Innovation Centre, Cell and Gene Therapy Catapult,

Marc Davies, Vice President of R&D, Leucid Bio

Anthony Davies, Founder & Chief Executive Officer, Dark Horse Consulting Group